Literature DB >> 27034810

Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD).

Karen E Matsukuma1, Dongguang Wei1, Kai Sun1, Rajendra Ramsamooj1, Mingyi Chen1.   

Abstract

Graft versus host disease (GVHD) is a common complication following allogeneic hematopoietic cell transplantation (HCT) that typically manifests as injury to the skin, gastrointestinal mucosa, and liver. In some cases, hepatic GVHD may be histologically indistinguishable from other disorders such as infection and drug-induced liver injury (DILI). Additionally, clinical signs and symptoms are frequently confounded by the superimposed effects of pretransplant chemoradiotherapy, immunotherapy (IT) (targeted to the underlying malignancy), GVHD prophylaxis, and infection. Thus, careful attention to and correlation with clinical findings, laboratory values, and histologic features is essential for diagnosis. This review, aimed at the practicing pathologist, will discuss current clinical and histologic criteria for GVHD, the approach to diagnosis of hepatic GVHD, and features helpful for distinguishing it from other entities in the differential diagnosis.

Entities:  

Keywords:  Hematopoietic cell transplantation (HCT); drug-induced liver injury (DILI); graft versus host disease (GVHD); hepatic lymphoma; immunotherapy (IT); post-transplant lymphoproliferative disorder (PTLD); veno-occlusive hepatic disease

Year:  2016        PMID: 27034810      PMCID: PMC4783620          DOI: 10.3978/j.issn.2078-6891.2015.036

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  40 in total

Review 1.  Primary hepatic lymphoma: a review.

Authors:  V S Avlonitis; D Linos
Journal:  Eur J Surg       Date:  1999-08

2.  Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.

Authors:  Mathangi Srinivasan; Ryan Flynn; Andrew Price; Ann Ranger; Jeffrey L Browning; Patricia A Taylor; Jerome Ritz; Joseph H Antin; William J Murphy; Leo Luznik; Mark J Shlomchik; Angela Panoskaltsis-Mortari; Bruce R Blazar
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

Review 3.  Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.

Authors:  George B McDonald
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

4.  The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.

Authors:  Enric Carreras; Marina Díaz-Beyá; Laura Rosiñol; Carmen Martínez; Francesc Fernández-Avilés; Montserrat Rovira
Journal:  Biol Blood Marrow Transplant       Date:  2011-06-25       Impact factor: 5.742

5.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

6.  Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients.

Authors:  H M Shulman; T Gooley; M D Dudley; T Kofler; R Feldman; D Dwyer; G B McDonald
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

Review 7.  Management of relapses after hematopoietic cell transplantation in T-cell non-Hodgkin lymphomas.

Authors:  Mehdi Hamadani; Sarah M Abu Kar; Saad Z Usmani; Bipin N Savani; Ernesto Ayala; Mohamed A Kharfan-Dabaja
Journal:  Semin Hematol       Date:  2013-11-15       Impact factor: 3.851

Review 8.  Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes.

Authors:  Andrew R Rezvani; Brenda M Sandmaier
Journal:  Curr Opin Hematol       Date:  2013-11       Impact factor: 3.284

9.  Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification.

Authors:  Christoph Loddenkemper; Thomas Longerich; Michael Hummel; Karen Ernestus; Ioannis Anagnostopoulos; Hans-Peter Dienes; Peter Schirmacher; Harald Stein
Journal:  Virchows Arch       Date:  2007-03-13       Impact factor: 4.064

10.  Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice.

Authors:  Annie Mirsoian; Myriam N Bouchlaka; Gail D Sckisel; Mingyi Chen; Chien-Chun Steven Pai; Emanuel Maverakis; Richard G Spencer; Kenneth W Fishbein; Sana Siddiqui; Arta M Monjazeb; Bronwen Martin; Stuart Maudsley; Charles Hesdorffer; Luigi Ferrucci; Dan L Longo; Bruce R Blazar; Robert H Wiltrout; Dennis D Taub; William J Murphy
Journal:  J Exp Med       Date:  2014-11-03       Impact factor: 14.307

View more
  15 in total

Review 1.  Graft-Versus-Host Disease After Liver Transplantation.

Authors:  Ashley Wood; Bijan Eghtesad; Christina C Lindenmeyer
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-26

2.  Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.

Authors:  Tahereh Rostami; Seyed Mostafa Monzavi; Hossein Poustchi; Ali Reza Khoshdel; Maryam Behfar; Amir Ali Hamidieh
Journal:  Int J Hematol       Date:  2020-10-08       Impact factor: 2.490

3.  Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy.

Authors:  Jaitip Tipanee; Ermira Samara-Kuko; Thierry Gevaert; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2022-06-16       Impact factor: 12.910

4.  Human Peripheral Blood Mononucleocyte Derived Myeloid Committed Progenitor Cells Mitigate H-ARS by Exosomal Paracrine Signal.

Authors:  Rishi Man Chugh; Payel Bhanja; Ximena Diaz Olea; Fang Tao; Kealan Schroeder; Ryan Zitter; Tanu Arora; Harsh Pathak; Bruce F Kimler; Andrew K Godwin; John M Perry; Subhrajit Saha
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

5.  Establishing a standardized system for review and adjudication of chronic graft-vs-host disease data in accordance with the National Institutes Consensus criteria.

Authors:  Djamilia Dierov; Nicholas Webb; Samira Fatmi; Chamberlain Nwanne; Cristi Ciolino; Kara Mosesso; Jimmy Nieves; Miguel-Angel Perales; Susan E Prockop; Doris M Ponce
Journal:  Adv Cell Gene Ther       Date:  2019-05-02

6.  Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.

Authors:  Premal D Lulla; Swati Naik; Spyridoula Vasileiou; Ifigeneia Tzannou; Ayumi Watanabe; Manik Kuvalekar; Suhasini Lulla; George Carrum; Carlos A Ramos; Rammurti Kamble; LaQuisa Hill; Jasleen Randhawa; Stephen Gottschalk; Robert Krance; Tao Wang; Mengfen Wu; Catherine Robertson; Adrian P Gee; Betty Chung; Bambi Grilley; Malcolm K Brenner; Helen E Heslop; Juan F Vera; Ann M Leen
Journal:  Blood       Date:  2021-05-13       Impact factor: 25.476

Review 7.  Graft-versus-host-disease after kidney transplantation: A case report and literature review.

Authors:  Yanhua Guo; Shouyang Ding; Hui Guo; Shenqiu Li; Xia Lu; Zhishui Chen; Zhonghua Klaus Chen; Changsheng Ming; Nianqiao Gong
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

8.  Multiorgan failure with fatal outcome after stem cell tourism.

Authors:  Željka Večerić-Haler; Špela Borštnar; Boštjan Luzar; Maja Jerše; Nika Kojc
Journal:  Eur J Med Res       Date:  2021-01-09       Impact factor: 2.175

9.  Depression following graft-versus-host disease in a patient with acute lymphoblastic leukaemia: A case report.

Authors:  Konstantinos Tsamakis; Christoph Mueller; Panagiotis Tsirigotis; Dimitrios Tsiptsios; Charalampos Tsamakis; Emmanouil Charakopoulos; Chistophis Charalampous; Demetrios A Spandidos; Athanasios Douzenis; Charalabos Papageorgiou; Ioannis Liappas; Emmanouil Rizos
Journal:  Mol Clin Oncol       Date:  2019-12-19

10.  Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice.

Authors:  Barbara Maximino Rezende; Priscila T T Bernardes; William Antonio Gonçalves; Carolina Braga de Resende; Rayssa Maciel Athayde; Thiago Vinicius Ávila; Débora Gonzaga Martins; Marina G M Castor; Mauro M Teixeira; Vanessa Pinho
Journal:  J Immunol Res       Date:  2019-11-03       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.